Page last updated: 2024-10-31

mirtazapine and Inappropriate ADH Syndrome

mirtazapine has been researched along with Inappropriate ADH Syndrome in 6 studies

Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.

Inappropriate ADH Syndrome: A condition of HYPONATREMIA and renal salt loss attributed to overexpansion of BODY FLUIDS resulting from sustained release of ANTIDIURETIC HORMONES which stimulates renal resorption of water. It is characterized by normal KIDNEY function, high urine OSMOLALITY, low serum osmolality, and neurological dysfunction. Etiologies include ADH-producing neoplasms, injuries or diseases involving the HYPOTHALAMUS, the PITUITARY GLAND, and the LUNG. This syndrome can also be drug-induced.

Research Excerpts

ExcerptRelevanceReference
"Depression is a common problem in elderly patients and frequently is treated with antidepressants."5.33Recurrent hyponatremia associated with citalopram and mirtazapine. ( Akcay, A; Bavbek, N; Kargili, A; Kaya, A, 2006)
"Depression is a common problem in elderly patients and frequently is treated with antidepressants."1.33Recurrent hyponatremia associated with citalopram and mirtazapine. ( Akcay, A; Bavbek, N; Kargili, A; Kaya, A, 2006)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lim, SY1
Bodagh, N1
Scott, G1
Hill, NE1
Tripathi, P1
Tomar, LR1
Goyal, P1
Singh, P1
Mogi, T1
Yoshino, A1
Ikemoto, G1
Nomura, S1
Bavbek, N1
Kargili, A1
Akcay, A1
Kaya, A1
Jagsch, C1
Marksteiner, J1
Seiringer, E1
Windhager, E1
Blass, DM1
Pearson, VE1

Other Studies

6 other studies available for mirtazapine and Inappropriate ADH Syndrome

ArticleYear
Hyponatraemia: the importance of obtaining a detailed history and corroborating point-of-care analysis with laboratory testing.
    BMJ case reports, 2019, Dec-09, Volume: 12, Issue:12

    Topics: Aged; Confusion; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Medical History Taking; Mir

2019
An unusual presentation of dose dependent SIADH secondary to mirtazapine therapy.
    The Australian and New Zealand journal of psychiatry, 2015, Volume: 49, Issue:11

    Topics: Aged; Antidepressive Agents; Citalopram; Depression; Dose-Response Relationship, Drug; Humans; Inapp

2015
Mirtazapine as an alternative for selective-serotonin-reuptake-inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone.
    Psychiatry and clinical neurosciences, 2012, Volume: 66, Issue:1

    Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Humans; Inappropriate ADH Syndrome; Male; Mianse

2012
Recurrent hyponatremia associated with citalopram and mirtazapine.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006, Volume: 48, Issue:4

    Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Citalopram; Depression; Diagnosis, Di

2006
Successful mirtazapine treatment of an 81-year-old patient with syndrome of inappropriate antidiuretic hormone secretion.
    Pharmacopsychiatry, 2007, Volume: 40, Issue:3

    Topics: Aged, 80 and over; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cital

2007
SIADH with multiple antidepressants in a geriatric patient.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:6

    Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bupropion; Cyclohexanols; Depressive Disorder; Hu

2000